Multidisciplinary effort boosts the George Washington University COVID-19 vaccine clinical trial. And when it comes to enrollment successes, Magnus points to GW's storied history in forming bonds with the local community. "The context of the HIV Prevention Network is so important and the relationships that helped us build," she says. "There’s nothing we can do by ourselves, it's really hand-in-hand with the community. We're fortunate that for decades we’ve had these connections. We trust them and they trust us, it’s open and transparent." Continue reading this article to see the process of setting up the site, the power of volunteers, and many more aspects of starting the COVID-19 Vaccine Clinical Trial.
A Game Winning Shot
Latest News
Dr. David Diemert, the director of the George Washington University Vaccine Research Unit, weighs in on President Donald Trump's executive order pushing for revisions to how children in the US are vaccinated and what that means for the future.
The GW VRU is a site for a clinical trial to examine Pfizer's new C. diff vaccine.
This was a phase 2, randomized, open-label, non-placebo controlled trial to evaluate two partial doses o the Modified Vaccinia Ankara-Bavarian Nordin (MVA-BN) vaccine for protection against mpox.
